MedTrace Logo

the Five-year Antibody Persistence After Immunization With IPV, MMR and HepA-L Vaccines

NCT07338851 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2026-01-14

No results posted yet for this study

Summary

This study evaluated the antibody persistence of Chinese children five years after they received four doses of sIPV, two doses of MMR vaccine and one dose of HepA-L vaccine.

Conditions

Sponsors & Collaborators

  • Shaanxi Provincial Center for Disease Control and Prevention

    collaborator OTHER

  • Hubei Provincial Center for Disease Control and Prevention

    collaborator OTHER

  • Jiangsu Provincial Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Anhui Provincial Center for Disease Control and Prevention

    collaborator UNKNOWN

  • Sichuan Provincial Center for Disease Control and Prevention

    collaborator UNKNOWN

  • China National Biotec Group Company Limited

    lead INDUSTRY

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-01-30
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07338851 on ClinicalTrials.gov